PL3500265T3 - Selektywne ligandy receptora estrogenowego beta - Google Patents
Selektywne ligandy receptora estrogenowego betaInfo
- Publication number
- PL3500265T3 PL3500265T3 PL17844206.7T PL17844206T PL3500265T3 PL 3500265 T3 PL3500265 T3 PL 3500265T3 PL 17844206 T PL17844206 T PL 17844206T PL 3500265 T3 PL3500265 T3 PL 3500265T3
- Authority
- PL
- Poland
- Prior art keywords
- estrogen receptor
- receptor beta
- selective ligands
- beta selective
- ligands
- Prior art date
Links
- 102000000509 Estrogen Receptor beta Human genes 0.000 title 1
- 108010041356 Estrogen Receptor beta Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662378015P | 2016-08-22 | 2016-08-22 | |
| US201662378014P | 2016-08-22 | 2016-08-22 | |
| PCT/US2017/047752 WO2018039110A1 (en) | 2016-08-22 | 2017-08-21 | Estrogen receptor beta selective ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3500265T3 true PL3500265T3 (pl) | 2024-03-11 |
Family
ID=61246295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17844206.7T PL3500265T3 (pl) | 2016-08-22 | 2017-08-21 | Selektywne ligandy receptora estrogenowego beta |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200377546A1 (pl) |
| EP (1) | EP3500265B1 (pl) |
| JP (1) | JP2019524864A (pl) |
| KR (1) | KR20190042651A (pl) |
| CN (1) | CN109937044A (pl) |
| AU (1) | AU2017317193A1 (pl) |
| CA (1) | CA3034641A1 (pl) |
| ES (1) | ES2966159T3 (pl) |
| PL (1) | PL3500265T3 (pl) |
| WO (1) | WO2018039110A1 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
| US6476012B2 (en) * | 2001-01-25 | 2002-11-05 | Yale University | Estradiol-16α-carboxylic acid esters as locally active estrogens |
| FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| GB0306718D0 (en) * | 2003-03-24 | 2003-04-30 | Sterix Ltd | Compound |
-
2017
- 2017-08-21 EP EP17844206.7A patent/EP3500265B1/en active Active
- 2017-08-21 ES ES17844206T patent/ES2966159T3/es active Active
- 2017-08-21 PL PL17844206.7T patent/PL3500265T3/pl unknown
- 2017-08-21 KR KR1020197008291A patent/KR20190042651A/ko not_active Withdrawn
- 2017-08-21 CN CN201780064601.0A patent/CN109937044A/zh active Pending
- 2017-08-21 JP JP2019511589A patent/JP2019524864A/ja active Pending
- 2017-08-21 AU AU2017317193A patent/AU2017317193A1/en not_active Abandoned
- 2017-08-21 CA CA3034641A patent/CA3034641A1/en active Pending
- 2017-08-21 US US16/326,525 patent/US20200377546A1/en not_active Abandoned
- 2017-08-21 WO PCT/US2017/047752 patent/WO2018039110A1/en not_active Ceased
-
2024
- 2024-05-03 US US18/654,724 patent/US20240294566A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3500265B1 (en) | 2023-10-04 |
| WO2018039110A1 (en) | 2018-03-01 |
| EP3500265A1 (en) | 2019-06-26 |
| CN109937044A (zh) | 2019-06-25 |
| ES2966159T3 (es) | 2024-04-18 |
| US20200377546A1 (en) | 2020-12-03 |
| US20240294566A1 (en) | 2024-09-05 |
| JP2019524864A (ja) | 2019-09-05 |
| KR20190042651A (ko) | 2019-04-24 |
| EP3500265A4 (en) | 2020-04-01 |
| CA3034641A1 (en) | 2018-03-01 |
| AU2017317193A1 (en) | 2019-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003023B (en) | Benzothiophene-based selective estrogen receptor downregulators | |
| IL285318A (en) | Estrogen receptor modulators | |
| IL295598A (en) | Selective estrogen receptor antagonists | |
| IL254254A0 (en) | chimeric antigen receptor | |
| GB201514875D0 (en) | Receptor | |
| GB201518816D0 (en) | Receptor | |
| GB201503742D0 (en) | Chimeric antigen receptor | |
| IL279990A (en) | Selective estrogen receptor antagonists | |
| GB201702617D0 (en) | Receptor | |
| IL250693B (en) | Royal ligands for the somatostatin receptor | |
| GB201519900D0 (en) | Chimeric antigen receptor | |
| PL3500265T3 (pl) | Selektywne ligandy receptora estrogenowego beta | |
| GB201320091D0 (en) | Selective glucocorticoid receptor ligands | |
| GB201701887D0 (en) | Receptor | |
| GB201700926D0 (en) | Receptor | |
| GB201703855D0 (en) | Multi doser scr system | |
| GB201703854D0 (en) | Multi doser scr system | |
| GB201301896D0 (en) | Novel Estrogen Receptor Ligands |